Predicting Leishmaniasis Treatment Success

This is a news story, published by ScienceDaily, that relates primarily to Ashton Trey Belew news.

Ashton Trey Belew news

For more Ashton Trey Belew news, you can click here:

more Ashton Trey Belew news

biology news

For more biology news, you can click here:

more biology news

ScienceDaily news

For more news from ScienceDaily, you can click here:

more news from ScienceDaily

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about

cutaneous leishmaniasis patients

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cutaneous leishmaniasis patient news, cutaneous leishmaniasis news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

human cutaneous leishmaniasis

ScienceDaily

•

Science

Researchers discover way to predict treatment success for parasitic skin disease

Summary

Nutrition label

79% Informative

Researchers discover way to predict treatment success for parasitic skin disease.

Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by the Leishmania parasite.

The standard drug used to treat the disease typically fails in about 40-70% of patients it is administered to.

Story Source: Journal Reference: - María Adelaida Gómez, Ashton Trey Belew , Deninson Alejandro Vargas , Lina Giraldo-Parra , Neal Alexander , David E. Rebellón-Sánchez , Theresa A. Alexander , Najib M. El-Sayed . Innate biosignature of treatment failure in human cutaneous leishmaniasis. Nature Communications , 2025 ; 16 ( 1 ) DOI: 10.1038 /s41467-025-58330-3 Cite This Page:.